Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DR26FBPYT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,969
Award facts
- Contract value 100% obligated
- $20,969.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,969.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and does not involve any identified subcontractor relationships.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.99 billion umbrella contract awarded on November 13, 2025. The PPV-G GEN V program represents part of the broader $30.3 billion federal pharmaceutical supply strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders covering an extensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and specialty medical products positions the company as a critical supplier within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FBPYT?
SPE2DR26FBPYT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FBPYT worth?
The government has obligated $20,969 on SPE2DR26FBPYT.
Is contract SPE2DR26FBPYT an order under another contract?
Yes. SPE2DR26FBPYT is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBPYT competed?
The extent of competition for SPE2DR26FBPYT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award